Generate a tailored SOP for Dr. Edgar Engleman. Improve your application with a focused, well-structured draft.
Edgar Engleman is a Professor of Pathology at Stanford University, specializing in Immunology and Rheumatology. He has contributed significantly to the understanding of immune cell biology and its implications in cancer and other life-threatening diseases. His research focuses on applying precise analytical tools to assess immune cell roles in the pathogenesis of various diseases, leading to the identification and reversal of disease-promoting immune abnormalities. Engleman has utilized mouse models and human tissues to ensure the clinical relevance of his findings, particularly in the generation of FDA-approved immunotherapies like Sipuleucel-T for advanced prostate cancer. His ongoing work also explores the role of immune cells in neurodegenerative and metabolic diseases, and he is developing therapies to induce immune tolerance for organ transplants. Prof. Engleman has been pivotal in clinical trials aimed at treating multiple cancers and has a keen interest in understanding mechanisms of immune evasion by tumors.
The Computer Science department emphasizes research potential. GRE General is currently optional but recommended for some tracks.